BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12202770)

  • 21. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
    Fisher LA; Samson L; Bessho T
    Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
    Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
    Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage.
    Larminat F; Bohr VA
    Nucleic Acids Res; 1994 Aug; 22(15):3005-10. PubMed ID: 8065913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
    PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.
    Weeda G; Donker I; de Wit J; Morreau H; Janssens R; Vissers CJ; Nigg A; van Steeg H; Bootsma D; Hoeijmakers JH
    Curr Biol; 1997 Jun; 7(6):427-39. PubMed ID: 9197240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
    Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
    EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex.
    Bessho T; Sancar A; Thompson LH; Thelen MP
    J Biol Chem; 1997 Feb; 272(6):3833-7. PubMed ID: 9013642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A.
    Gu Y; Patterson AV; Atwell GJ; Chernikova SB; Brown JM; Thompson LH; Wilson WR
    Mol Cancer Ther; 2009 Jun; 8(6):1714-23. PubMed ID: 19509245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair.
    Wang X; Peterson CA; Zheng H; Nairn RS; Legerski RJ; Li L
    Mol Cell Biol; 2001 Feb; 21(3):713-20. PubMed ID: 11154259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
    Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
    Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
    Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
    Yang LY; Li L; Jiang H; Shen Y; Plunkett W
    Clin Cancer Res; 2000 Mar; 6(3):773-81. PubMed ID: 10741696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G; Imperatori L; Stefanini M; D'Incalci M
    Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer.
    Priya Doss CG; Nagasundaram N
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1265-81. PubMed ID: 24158589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
    Zhang N; Liu X; Li L; Legerski R
    DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
    Lee KB; Parker RJ; Bohr V; Cornelison T; Reed E
    Carcinogenesis; 1993 Oct; 14(10):2177-80. PubMed ID: 8222071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.
    Melton DW; Ketchen AM; Núñez F; Bonatti-Abbondandolo S; Abbondandolo A; Squires S; Johnson RT
    J Cell Sci; 1998 Feb; 111 ( Pt 3)():395-404. PubMed ID: 9427687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
    Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.